Low vision can affect one or both eyes and be caused by aging, birth defects, injury or complications from disease. Those who suffer from vision loss lose their independence and experience a poor quality of life. Everyday tasks such as using a cell phone, driving, reading a favorite novel or even watching the grandchildren play, become challenging and often impossible.
USC Roski Eye Institute Low Vision Rehabilitation Service
The USC Roski Eye institute is committed to enhancing the lives of those diagnosed with low vision. USC Roski Eye Institute brings hope to those who suffer from low vision with new vision rehabilitation services. Assistant Professor of Clinical Ophthalmology, Rachel A. Young, O.D., offers several services such as prescription eyewear, magnifiers or filters and other forms of assistive technology to treat low vision. Patients are also offered personalized counseling or training to improve their general quality of life.
In addition physicians and residents are educated in the diagnosis and treatment of low vision. Dr. Young organized an annual low vision symposium for USC Roski Eye Institute residents. Vision rehabilitation specialists were invited to discuss the latest in low vision treatments. Numerous medical device suppliers also demonstrated the newest technological advances in vision rehabilitation devices.
USC Roski Eye Institute Making a Difference in the Fight Against AMD
Researchers at the USC Roski Eye Institute have made great strides in the treatment of vision loss caused by devastating diseases such as age-related macular degeneration (AMD). Mark S. Humayun, MD, PhD, and David R. Hinton, MD, received nearly $38 million from the California Institute for Regenerative Medicine (CIRM) to develop a stem cell-based treatment for AMD. AMD affects over 1.75 million people age 50 and older in the United States. The leading cause of blindness and vision loss among the elderly, AMD is a central retinal disease that impacts the area of the eye that helps process images, leading to catastrophic vision loss. It targets central vision, resulting in the inability to read, recognize faces or even drive. The disease causes a loss of crucial retinal pigment epithelial (RPE) cells, which are essential to the survival of photoreceptors (light sensitive cells). To restore those RPE cells, the USC Roski Eye Institute team developed a unique procedure to grow thin sheets of stem cell-derived cells to be surgically implanted in the eye, replacing diseased sheets and restoring photoreceptors needed for vision. Phase 1 human clinical trial at the USC Roski Eye institute has already begun.
Schedule an Appointment at the USC Roski Eye Institute Today!
The exceptional eye doctors at USC Roski Eye Institute are experts at diagnosing and treating a wide variety of eye conditions. To receive a comprehensive eye exam and ensure that your vision is protected from diabetes-related conditions, please complete our online contact form or call 323-442-6335 today!
by Debbie Mitra